Treating diabetes today with gliclazide MR: a matter of numbers

Hypoglycemia with gliclazide MR in women with type 2 diabetes. A continuous glucose monitoring study

Background Hypoglycemia is usually a limiting factor in the treatment of type 2 diabetes and it may be asymptomatic many times. Sulfonylureas are a group of anti-diabetic drugs associated with an increased risk of hypoglycemia, but, within this group, gliclazide MR seems to be associated with a fewer number of these episodes. Large-scale studies suggest that the incidence of hypoglycemia may be...

prevalence of atopic dermatitis in children with type 1 diabetes mellitus in southeastern of iran (kerman province): a case-control study

چکیده ندارد.

Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.

OBJECTIVE To compare the efficacy and tolerability of metformin, rosiglitazone and gliclazide MR as monotherapy and in combination in the treatment of type 2 diabetes. SUBJECTS AND METHODS 250 patients treated with oral antidiabetic agents for at least 24 weeks in monotherapy or in combination therapy were included in this retrospective study. RESULTS As monotherapy the reduction of fasting...

What's the matter with kids today?

Treating diabetes with surgery.

THAT TYPE 2 DIABETES REMISSION MAY BE INDUCED BY BARiatric surgery in patients with grade 2 (body mass index [BMI] 35) and grade 3 (BMI 40) obesity soon after operation and preceding weight loss has stimulated new ideas regarding diabetes treatment. Some investigators have proposed surgical intervention for patients with type 2 diabetes with grade 1 obesity (BMI 30), with some even proposing ba...